Irvine Scientific Announces Launch of BalanCD™ Cell Culture Media Product Line
Mar 27, 2012 | Posted in Industrial Cell Culture
Irvine Scientific is pleased to announce the launch of their BalanCD™ Cell Culture Media Product Line, a next-generation cell culture product portfolio responding to today’s challenges for media used for industrial biopharmaceutical applications. The new flagship product line expands Irvine Scientific’s current portfolio of animal-component-free and chemically-defined media with the addition of four new purpose built fed-batch media products; BalanCD™ CHO Growth A and BalanCD™ CHO Feed 1, a matched pair fed-batch media culture system and two additional feeds developed to complement commonly available commercial growth media, BalanCD™ CHO Feed 2 and BalanCD™ CHO Feed 3.
“The BalanCD™ line meets our customer’s expectations for cell culture product design, quality, and performance.” said Tom Fletcher, Director of Research and Development, Industrial Cell Culture. “We’ve taken an integrated approach to addressing critical issues, such as the risks introduced through raw material sourcing and supply, from early product development through scale-up and commercial supply. Any product that carries the BalanCD™ name assures our customer's a series of stringent criteria have been met. ” BalanCD™ products are formulated using raw materials with a scalable and well characterized supply chain, intended for large-scale biopharmaceutical processes, and provide for highly reliable and reproducible performance. Each formulation was developed using Irvine Scientific’s Rational Culture Media Design™ approach to ensure extraneous components that may contribute to unwanted bio-production costs or risks are eliminated. The end result is optimized cell culture media products that meet the demands of today’s bioproduction customer.
Each of the BalanCD™ CHO cell culture media products are available in both liquid and powder formats. For additional information please visit our website at www.irvinesci.com or contact us at 800-437-5706.